Allo vs Hypomethylating/Best Supportive Care in MDS (BMTCTN1102)
Public ClinicalTrials.gov record NCT02016781. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center Biologic Assignment Trial Comparing Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients w/Intermediate-2 & High Risk Myelodysplastic Syndrome (BMTCTN1102)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed as a multicenter trial, with biological assignment to one of two study arms; Arm 1: Reduced intensity conditioning allogeneic hematopoietic cell transplantation (RIC-alloHCT), Arm 2: Non-Transplant Therapy/Best Supportive Care.
Study identification
- NCT ID
- NCT02016781
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 384 participants
Conditions and interventions
Conditions
Interventions
- Allogeneic Hematopoietic Cell Transplant Procedure
- Hypomethylating Therapy / Best Supportive Care Procedure
Procedure
Eligibility (public fields only)
- Age range
- 50 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 15, 2013
- Primary completion
- Oct 4, 2021
- Completion
- Oct 4, 2021
- Last update posted
- Mar 2, 2023
2013 – 2021
United States locations
- U.S. sites
- 37
- U.S. states
- 24
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope National Medical Center | Duarte | California | 91010 | — |
| Stanford Hospital and Clinics | Stanford | California | 94305 | — |
| University of Florida College of Medicine | Gainesville | Florida | 32610-0277 | — |
| H. Lee Moffitt Cancer Center | Tampa | Florida | 33624 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| University of Chicago | Chicago | Illinois | 60637-1470 | — |
| University of Kansas Hospital | Kansas City | Kansas | 66160 | — |
| University of Kentucky | Lexington | Kentucky | 40536 | — |
| University of Maryland Medical Systems - Greenebaum Cancer Center | Baltimore | Maryland | 21201 | — |
| Johns Hopkins | Baltimore | Maryland | 21231 | — |
| Dana Farber Cancer Institute/Brigham & Women's | Boston | Massachusetts | 02115 | — |
| Dana Farber Cancer Institute/Massachusetts General Hospital | Boston | Massachusetts | 02115 | — |
| Karmanos Cancer Institute/BMT | Detroit | Michigan | 48201 | — |
| Mayo Clinic - Rochester | Rochester | Minnesota | 55905 | — |
| Washington University/Barnes Jewish Hospital | St Louis | Missouri | 63110 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| Mount Sinai Hospital | New York | New York | 10029 | — |
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10065 | — |
| University of North Carolina Hospital at Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27599 | — |
| Duke University Medical Center | Durham | North Carolina | 27705 | — |
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 | — |
| Jewish Hospital BMT Program | Cincinnati | Ohio | 45236 | — |
| University Hospitals of Cleveland/ Case Western | Cleveland | Ohio | 44106 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Ohio State/Arthur G. James Cancer Hospital | Columbus | Ohio | 43210 | — |
| Oregon Health & Science University | Portland | Oregon | 97239-3098 | — |
| University of Pennsylvania Cancer Center | Philadelphia | Pennsylvania | 19104 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232-8210 | — |
| Baylor College of Medicine/The Methodist Hospital | Houston | Texas | 77030 | — |
| University of Texas/MD Anderson CRC | Houston | Texas | 77030 | — |
| University of Utah Med School | Salt Lake City | Utah | 84132 | — |
| Virginia Commonwealth University MCV Hospitals | Richmond | Virginia | 23298 | — |
| Fred Hutchinson Cancer Research Center | Seattle | Washington | 98109 | — |
| West Virginia University Hospital | Morgantown | West Virginia | 26506 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53211 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated MDS trials
Other public records listing MDS. Sorted by last update posted; newest first. Not a recommendation.
- NCT07702578: A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation Recruiting
- NCT01861106: Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations Recruiting
- NCT03050268: Familial Investigations of Childhood Cancer Predisposition Recruiting
- NCT05177211: Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL) Active, not recruiting
- NCT07493538: MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases Recruiting
- NCT04187105: BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02016781, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 2, 2023 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02016781 live on ClinicalTrials.gov.